ONCODE AND ASTELLAS LAUNCH FLT3 COPAY PROGRAM TO ENHANCE ACCESS TO AML DIAGNOSTICS IN MALAYSIA
Kuala Lumpur, Malaysia – 31 May 2025 – Oncode Scientific, in collaboration with Astellas Pharma — a leading pharmaceutical company headquartered in Japan — has officially launched the FLT3 Testing Copay Program, a major initiative to expand access to precision diagnostics for relapsed or refractory acute myeloid leukemia (AML) patients within Malaysia’s public healthcare system. …